Stock Updates

Is Celgene Corporation(NASDAQ: CELG), a large market cap stock a smart buy?

With a market cap of has a large market cap size. Celgene Corporation (NASDAQ: CELG) has been on the stock market since its IPO date on the 3/26/1990. Celgene Corporation is in the Biotechnology industry and Healthcare sector. Average volume for Celgene Corporation, is 4294.93, and so far today it has a volume of 2142592. Performance year to date since the 3/26/1990 is -14.61%.

To help you determine whether Celgene Corporation is undervalued the following values will help you decide. P/E is 49.47 and forward P/E is 14.55. PEG perhaps more useful shows that Celgene Corporation has a value for PEG of 2.25. P/S ratio is 8.24 and the P/B ratio is 15.73. The P/Cash and P/Free cash flow is 13.99 and 34.73 respectively.

At the current price Celgene Corporation is trading at, 105.37 (3.04% today), Celgene Corporation has a dividend yield of *TBA, and this is covered by a payout ratio of 0.00%. Earnings per share (EPS) is 2.07, and this is looking to grow in the next year to 23.72% after growing -18.80% this past year. EPS growth quarter over quarter is 15.00%, and 20.70% for sales growth quarter over quarter.

The number of shares outstanding is 780.6, and the number of shares float is 772.42. The senior management bring insider ownership to 0.20%, and institutional ownership is at 80.50%. The float short is 1.08%, with the short ratio at a value of 1.94. Management has seen a return on assets of 6.90%, and also a return on investment of 8.90%.

The ability for Celgene Corporation, to deal with debt, means it current ratio is 4.6, and quick ratio is 4.3. Long term debt/equity is 2.81 and total debt/equity is 0. In terms of margins, Celgene Corporation has a gross margin of 95.60%, with its operating margin at 24.50%, and Celgene Corporation has a profit margin of 17.40%.

The 52 week high is -25.12%, with 13.33% being its 52 week low. The 20 day simple moving average is 3.15% and the 200 day simple moving average is -1.64%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Mark Hines

Leave a Comment